Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis.
Xuereb L, Go PH, Kaur B, Akrawe S, Borgi J, Paone G, Morgan JA. Should Patients with Hepatic Fibrosis Undergo LVAD Implantation: A Comparative Analysis. ASAIO J. 2016 Jul-Aug;62(4):498-500.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
The purpose of our study was to evaluate outcomes in patients with hepatic fibrosis at the time of LVAD implantation. There were five (2.1%) patients with preoperative hepatic fibrosis with a mean age of 51.2 ± 16.8 years. Survival at 180 days was significantly reduced in patients with hepatic fibrosis, 40.0% vs. 88.0%; p = 0.001. Hepatic fibrosis was a significant independent predictor of mortality in multivariate analysis (hazard ratio [HR] 2.27, p = 0.036).
Medical Subject Headings
Adult; Aged; Heart-Assist Devices; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis